JPS609026B2 - Method for producing sulfur-containing pyridine derivative - Google Patents
Method for producing sulfur-containing pyridine derivativeInfo
- Publication number
- JPS609026B2 JPS609026B2 JP2348875A JP2348875A JPS609026B2 JP S609026 B2 JPS609026 B2 JP S609026B2 JP 2348875 A JP2348875 A JP 2348875A JP 2348875 A JP2348875 A JP 2348875A JP S609026 B2 JPS609026 B2 JP S609026B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- methyl
- pyridine
- hydroxy
- methylmercaptomethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 3
- 229910052717 sulfur Inorganic materials 0.000 title claims description 3
- 150000003222 pyridines Chemical class 0.000 title description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 title 1
- 239000011593 sulfur Substances 0.000 title 1
- 239000002253 acid Substances 0.000 claims description 13
- 150000003839 salts Chemical class 0.000 claims description 9
- VGWRNXUFWFDSCH-UHFFFAOYSA-N 4-(ethylaminomethyl)-2-methyl-5-(methylsulfanylmethyl)pyridin-3-ol Chemical compound CCNCC1=C(CSC)C=NC(C)=C1O VGWRNXUFWFDSCH-UHFFFAOYSA-N 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- -1 2-methyl-3-hydroxy-4-ethylaminomethyl-5-methyl-mercaptomethyl-pyridine Chemical compound 0.000 description 13
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000002585 base Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- YZCFCAJTKKMAAN-UHFFFAOYSA-N 4-(hydroxymethyl)-2-methyl-5-(methylsulfanylmethyl)pyridin-3-ol Chemical compound CSCC1=CN=C(C)C(O)=C1CO YZCFCAJTKKMAAN-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- TWBYWOBDOCUKOW-UHFFFAOYSA-N isonicotinic acid Chemical compound OC(=O)C1=CC=NC=C1 TWBYWOBDOCUKOW-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000011007 phosphoric acid Nutrition 0.000 description 2
- WLJVNTCWHIRURA-UHFFFAOYSA-N pimelic acid Chemical compound OC(=O)CCCCCC(O)=O WLJVNTCWHIRURA-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- OXQGTIUCKGYOAA-UHFFFAOYSA-N 2-Ethylbutanoic acid Chemical compound CCC(CC)C(O)=O OXQGTIUCKGYOAA-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 159000000032 aromatic acids Chemical class 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical compound OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- YPGCWEMNNLXISK-UHFFFAOYSA-N hydratropic acid Chemical compound OC(=O)C(C)C1=CC=CC=C1 YPGCWEMNNLXISK-UHFFFAOYSA-N 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- HYHCSLBZRBJJCH-UHFFFAOYSA-M sodium hydrosulfide Chemical compound [Na+].[SH-] HYHCSLBZRBJJCH-UHFFFAOYSA-M 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- IIACRCGMVDHOTQ-UHFFFAOYSA-N sulfamic acid group Chemical class S(N)(O)(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-N 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
- C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
Description
【発明の詳細な説明】
本発明は、2−メチル−3−ヒドロキシ−4−エチルア
ミノメチル−5−メチル−メルカプトメチルーピリジン
(1)およびその酸付加塩の新規で有利な製法に関する
。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a new and advantageous process for the preparation of 2-methyl-3-hydroxy-4-ethylaminomethyl-5-methyl-mercaptomethyl-pyridine (1) and its acid addition salts.
前記化合物は価値ある薬理学的性質を示す。Said compounds exhibit valuable pharmacological properties.
従って、それらは医薬剤として使用され得る。特にそれ
らは脳波において好ましい作用を示す。前記化合物にい
くつかの製法が既知であるが、しかしながらこれらの方
法は各種の不利点を有する。すなわち1つにはそれらは
純粋な生成物を生成せず、そして1つには収量が不満足
である。今や前記化合物が特に本発明の新規な製法によ
り著しい高収率でそして高純度で得られることが見出さ
れた。本発明の対象は、一般式0
(式中Xは○またはSでありそしてRは日、1〜4個の
炭素原子を有するアルキルまたはペンジルである)のピ
リジン誘導体または前記化合物の塩をエチルアミンで処
理しそして所望により得られた塩基(1)を酸で処理し
てその生理学的に許容し得る酸付加塩の1種に変換する
ことを特徴とする、2ーメチルー3ーヒドロキシ−4−
エチルアミノメチル−5ーメチルメルカプトメチルーピ
リジン(1)およびその酸付加塩の製法である。Therefore, they can be used as pharmaceutical agents. In particular, they show favorable effects on brain waves. Several methods are known for the preparation of said compounds, however these methods have various disadvantages. On the one hand, they do not produce pure products, and on the other hand, the yields are unsatisfactory. It has now been found that said compounds are obtainable in particularly high yields and in high purity by the novel process of the invention. The subject of the present invention is to prepare pyridine derivatives of the general formula 0, in which X is O or S and R is alkyl or pendyl having 1 to 4 carbon atoms, or salts of said compounds with ethylamine. 2-methyl-3-hydroxy-4-, characterized in that the base (1) obtained is converted by treatment with an acid into one of its physiologically acceptable acid addition salts.
This is a method for producing ethylaminomethyl-5-methylmercaptomethyl-pyridine (1) and its acid addition salt.
出発物質の1種すなわち2ーメチルー3ーヒドロキシ−
4−ヒドロキシメチル−5ーメチルメルカプトメチルー
ピリジン(ロ)(式中Xは○でありそしてRは日である
)は既知である。式0の他の化合物もまた例えば式D(
式中×は○でありそしてRは日である)の化合物をSO
C12と反応させて2−メチル−3ーヒドロキシ−4−
クロロメチル−5−メチルメルカプトメチルーピリジン
を生成させそして次いで式R−X−Na(例えばナトリ
ウムメチレート、硫化水素ナトリウムまたはナトリウム
ベンジルメルカプチド)のアルコレートまたはメルカプ
チドと反応せしめるような既知の方法で製造され得る。
エチルアミンとの式0の化合物の反応はそれが低沸点で
あるゆえに、所望により例えば窒素またはアルゴンのよ
うな不活性ガスを添加して加圧下(約10仇t以下)で
行なうのが適当である。One of the starting materials, namely 2-methyl-3-hydroxy-
4-Hydroxymethyl-5-methylmercaptomethyl-pyridine (b) (wherein X is O and R is day) is known. Other compounds of formula 0 may also be used, such as those of formula D (
In the formula, × is ○ and R is day)
2-methyl-3-hydroxy-4- by reacting with C12
by known methods such as forming chloromethyl-5-methylmercaptomethyl-pyridine and then reacting with an alcoholate or mercaptide of the formula R-X-Na (e.g. sodium methylate, sodium hydrogen sulfide or sodium benzylmercaptide). can be manufactured.
Due to its low boiling point, the reaction of the compound of formula 0 with ethylamine is suitably carried out under pressure (less than about 10 tons), optionally with the addition of an inert gas such as nitrogen or argon. .
不活性溶媒も存在することができ、例えばメタノール、
エタノール、プロパノール、イソプロパノールまたはブ
タノールのようなアルコールである。反応温度は約20
qoないし約250こC好ましくは13000なし、し
230つ○が適当である。所望により得られた塩基(1
)は通常の方法によって酸と反応させて相当する酸付加
塩に転換し得る。Inert solvents may also be present, e.g. methanol,
An alcohol such as ethanol, propanol, isopropanol or butanol. The reaction temperature is about 20
qo to about 250 C, preferably 13,000 or less, to 230 C is appropriate. Base obtained as desired (1
) can be converted into the corresponding acid addition salt by reaction with an acid by conventional methods.
この反応においては生理学的に許容し得る塩を生成する
ような酸が使用され得る。すなわち無機酸例えば硫酸、
硝酸、塩酸はたは臭化水素酸のよいなハロゲン化水素酸
、オルトりん酸のようなりん酸またはスルフアミン酸が
使用され、さらに有機酸特に脂肪族、脂環式、芳香脂肪
族、芳香族または複索環式のモノーまたはポリ塩基性カ
ルボン酸またはスルホン酸、例えばぎ酸、酢酸、プロピ
オン酸、ビバリン酸、ジェチル酢酸、マロン酸、こはく
酸、ピメリン酸、フマル酸、マレィン酸、乳酸、酒石酸
、りんご酸、〈えん酸、グルコン酸、アスコルビン酸、
安息香酸、サリチル酸、2ーフェニルプロピオン酸、ニ
コチン酸、ィソニコチン酸、メタンスルホン酸またはェ
タンスルホン酸、ェタンジスルホン酸、2−ヒドロキシ
ェタンスルホン酸、ベンゼンスルホン酸、p−トルェン
スルホン酸またはナフタリンモノおよびジスルホン酸も
また使用され得る。所望により式1の化合物の遊離塩基
がその塩から例えば水酸化ナトリウムまたはカルシウム
あるいは炭酸ナトリウムまたはカルシウムのような強塩
基で処理することによって遊離され得る。Acids that produce physiologically acceptable salts may be used in this reaction. i.e. inorganic acids such as sulfuric acid,
Hydrohalic acids such as nitric acid, hydrochloric acid or hydrobromic acid, phosphoric acids such as orthophosphoric acid or sulfamic acids are used, as well as organic acids, especially aliphatic, cycloaliphatic, araliphatic and aromatic acids. or polycyclic mono- or polybasic carboxylic or sulfonic acids, such as formic acid, acetic acid, propionic acid, bivalic acid, diethyl acetic acid, malonic acid, succinic acid, pimelic acid, fumaric acid, maleic acid, lactic acid, tartaric acid , malic acid, < enoic acid, gluconic acid, ascorbic acid,
Benzoic acid, salicylic acid, 2-phenylpropionic acid, nicotinic acid, isonicotinic acid, methanesulfonic acid or ethanesulfonic acid, ethanedisulfonic acid, 2-hydroxyethanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid or naphthalene mono and disulfonic acids may also be used. If desired, the free base of a compound of formula 1 can be liberated from its salt by treatment with a strong base such as, for example, sodium or calcium hydroxide or sodium or calcium carbonate.
本発明による方法は塩基(1)の化合物およびその酸付
加塩を著しい高収率でそして著しく純粋な形態(実際上
副生成物を含まない)で生成する。このようにして得ら
れた化合物はさらに精製することないこ通常の医薬製剤
に直接転換され得る。実施例 1
メタノール750机中2ーメチルー3−ヒドロキシ−4
−メトキシメチルー5ーメチルメルカプトメチルーピリ
ジン150夕の溶液を礎洋付オートクレープ中で液体エ
チルアミンと一緒に14000に6時間加熱する。The process according to the invention produces the compounds of base (1) and their acid addition salts in extremely high yields and in extremely pure form (virtually free of by-products). The compounds thus obtained can be converted directly into conventional pharmaceutical preparations without further purification. Example 1 2-methyl-3-hydroxy-4 in methanol 750 units
A solution of 150 ml of methoxymethyl-5-methylmercaptomethyl-pyridine is heated with liquid ethylamine to 14,000° C. for 6 hours in a submerged autoclave.
この混合物を濃縮し、エタノール性塩酸300の‘を残
留物に添加し、混合物を冷却し、そして得られた2−メ
チル−3−ヒドロキシ−4−エチルアミノメチル−5−
メチルメルカプトメチルーピリジンジ塩酸塩を吸引ろ過
しそして少量のメタノールおよびエーテルで洗浄する(
融点23800)。実施例 2
縄杵付オ−トクレープ中で液体エチルアミン1.8そお
よび氷袷メタノール1.8その混合物を2−メチル−3
−ヒドロキシ−4−ヒドロキシメチル−5ーメチルメル
カプトメチルーピリジン1k9に添加する。The mixture was concentrated, 300' of ethanolic hydrochloric acid was added to the residue, the mixture was cooled and the resulting 2-methyl-3-hydroxy-4-ethylaminomethyl-5-
The methylmercaptomethyl-pyridine dihydrochloride is filtered off with suction and washed with a small amount of methanol and ether (
Melting point 23800). Example 2 In an autoclave with a rope pestle, a mixture of 1.8 g of liquid ethylamine and 1.8 g of methanol was mixed with 2-methyl-3
-Hydroxy-4-hydroxymethyl-5-methylmercaptomethyl-pyridine 1k9.
オートクレープ中に1瓜tの窒素圧を与えた後に前記混
合物を鷹拝しながら6時間150℃に加熱する。混合物
を冷却し、濃縮し、残留物をィソプロパノールに溶解さ
せそして再び濃縮する。得られた粗塩基をメタノール中
に溶解させ、この溶液を木炭で処理しそしてろ過する。
塩酸をpH1.5になるまでろ液に加える。ジ塩酸塩が
冷却下に晶出する(融点238℃)。実施例 3
2−メチル−3ーヒドoキシー4ーメルカプトメチルー
5ーメチルメルカプトメチルーピリジン645の9、エ
タノール2泌およびエチルアミン2の‘の混合物を封管
中で150ooに6時間加熱する。After applying 1 ton of nitrogen pressure in the autoclave, the mixture is heated to 150° C. for 6 hours under pressure. The mixture is cooled, concentrated, the residue is dissolved in isopropanol and concentrated again. The crude base obtained is dissolved in methanol, the solution is treated with charcoal and filtered.
Add hydrochloric acid to the filtrate until pH 1.5. The dihydrochloride crystallizes out on cooling (melting point 238° C.). Example 3 A mixture of 2-methyl-3-hydroxy-4-mercaptomethyl-5-methylmercaptomethyl-pyridine 645, ethanol 2, and ethylamine 2' is heated to 150 oo for 6 hours in a sealed tube.
前記混合物を濃縮し、残留物をシリカゲル上クロロホル
ム/メタノール/酢酸エチル(7:2:1)でクロマト
グラフィー処理しそして2ーメチルー3ーヒドロキシー
4ーエチルアミノメチル一5−メチルメルカプトメチル
ーピリジンを得る(融点鼠〜6500)。実施例 4
封管中2−メチル−3−ヒドロキシ−4・5ービス−(
メチルメルカプトメチル)−ピリジン690の9、イソ
プロパノール2の【およびエチルアミン2の‘の混合物
を220午0に6時間加熱する。The mixture is concentrated and the residue is chromatographed on silica gel with chloroform/methanol/ethyl acetate (7:2:1) to give 2-methyl-3-hydroxy-4-ethylaminomethyl-5-methylmercaptomethyl-pyridine ( Melting point ~6500). Example 4 2-methyl-3-hydroxy-4,5-bis-(
A mixture of methyl mercaptomethyl)-pyridine, 690 parts, isopropanol, 2 parts, and ethylamine, 2 parts', is heated to 220:00 for 6 hours.
前記混合物を濃縮し、シリカゲル上でクロマトグラフィ
ー処理しそして2ーメチルー3−ヒドロキシ−4ーエチ
ルアミノメチル−5−メチルメルカプトメチルーピリジ
ンを得る(融点64〜65oo)実施例 52−メチル
−3ーヒドロキシー4ーベンジルメルカプトメチル一5
ーメチルメルカプトメチルーピリジンを実施例4と同様
に処理してそれと同一の最終生成物を得る。The mixture is concentrated and chromatographed on silica gel to give 2-methyl-3-hydroxy-4-ethylaminomethyl-5-methylmercaptomethyl-pyridine (melting point 64-65oo) Example 52-Methyl-3-hydroxy-4 -benzylmercaptomethyl-5
-Methylmercaptomethyl-pyridine is treated analogously to Example 4 to give the same final product.
Claims (1)
炭素原子を有するアルキルまたはベンジルである)のピ
リジン誘導体またはその酸付加塩をエチルアミンで処理
しそして所望により得られる塩基(I)を酸で処理して
その生理学的に許容し得る酸付加塩に変換することを特
徴とする、2−メチル−3−ヒドロキシ−4−エチルア
ミノメチル−5−メチルメルカプトメチル−ピリジン(
I)およびその酸付加塩の製法。[Scope of Claims] 1 Formula II ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (wherein X is O or S and R is H, alkyl or benzyl having 1 to 4 carbon atoms) A 2-methyl- 3-Hydroxy-4-ethylaminomethyl-5-methylmercaptomethyl-pyridine (
I) and its acid addition salt production method.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2459334.8 | 1974-12-16 | ||
DE19742459334 DE2459334A1 (en) | 1968-12-05 | 1974-12-16 | Cerebrally active pyridine derivs prepn - viz 2-methyl-3-hydroxy-4-ethylaminomethyl-5- methylthiomethyl-pyridine and salts |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5170765A JPS5170765A (en) | 1976-06-18 |
JPS609026B2 true JPS609026B2 (en) | 1985-03-07 |
Family
ID=5933500
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2348875A Expired JPS609026B2 (en) | 1974-12-16 | 1975-02-27 | Method for producing sulfur-containing pyridine derivative |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPS609026B2 (en) |
CH (1) | CH602651A5 (en) |
HU (1) | HU170193B (en) |
-
1975
- 1975-02-27 JP JP2348875A patent/JPS609026B2/en not_active Expired
- 1975-12-15 HU HUME001929 patent/HU170193B/hu unknown
- 1975-12-16 CH CH1628975A patent/CH602651A5/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPS5170765A (en) | 1976-06-18 |
HU170193B (en) | 1977-04-28 |
CH602651A5 (en) | 1978-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20010053294A (en) | Method for producing ortho-alkylated benzoic acid derivatives | |
SU481155A3 (en) | Production method - (furyl-methyl) morphinans | |
TW201912656A (en) | Method for preparing sugammadex sodium and crystalline form thereof | |
SK14672001A3 (en) | Novel synthesis and crystallization of piperazine ring-containing compounds | |
CN113214223B (en) | Preparation method of Voranolan fumarate impurity | |
JPS609026B2 (en) | Method for producing sulfur-containing pyridine derivative | |
Hünig et al. | A convenient synthesis of 2, 2', 6, 6'-Tetramethyl-4, 4'-bipyridine and its oxidation to 2, 2', 6, 6'-Tetracarboxy-4, 4'-bipyridine | |
CA1068710A (en) | Preparation of 2-methyl-3-hydroxy-4-ethylaminomethyl-5-methylmercaptomethyl-pyridine and its acid addition salts | |
US3583992A (en) | 1-methyl-d-lysergic acid-dihydroxy-alkyl-amides | |
JPS6028838B2 (en) | Method for producing nitrogen-containing polycyclic compound | |
JP2815654B2 (en) | Novel 4-substituted-3,5-dimethylpicolinic acid compound and method for producing the same | |
JPS602293B2 (en) | Glycyrrhetinic acid derivative | |
CN111718295B (en) | Preparation method of high-purity milrinone | |
US3136779A (en) | 1-propargyl-2-methyl-3-phenyl-3-propionyloxy-pyrrolidines | |
CN111718292B (en) | Milrinone intermediate compound | |
EP0013153B1 (en) | 6-amino pyridine carboxylic acid derivatives, a process for their preparation and pharmaceutical compositions containing them | |
CN108101892A (en) | A kind of Chrysin non-natural amino acid derivative and its preparation method and application | |
KR950008527B1 (en) | A process for the preparation of pyridine derivatives | |
JPH01163175A (en) | Furan-2-one derivative | |
CN119143619A (en) | Synthesis method of phenylglycine derivative | |
KR100516383B1 (en) | New manufacturing process of dihydrocarbostyril derivatives | |
KR20250014615A (en) | Process for preparing vonoprazan fumarate | |
US3120531A (en) | 10-bromoyohimbine alkaloids | |
KR820001121B1 (en) | Process for preparing 2-amino-methyl pyrolidine | |
KR100297802B1 (en) | Method for preparing 2- (3-trifluoromethyl) anilinonicotinic acid 2- (N-morpholine) ethyl. |